Neonatal jaundice. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Control group: The neonate with jaundice will receive placebo. The number of placebo drops per day is similar to the number of bilinaster drops. Intervention 2: Intervention group: The
Sponsors
Vice chancellor for research, Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 14 Days
Inclusion criteria
Inclusion criteria: All term neonate with jaundice weighted between 2500 -4000 gr and fed with breast milk
Exclusion criteria
Exclusion criteria: blood incompatibility or Rh incompatibility Fauvism immaturity need for blood transfusions hemolysis infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Baby serum total bilirubin. Timepoint: Every 24 hours for 5 days. Method of measurement: Laboratory test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of hospitalization days. Timepoint: At the time of discharge. Method of measurement: From the time of admission to discharge.;The incidence of complications arising from the use of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;Evaluation of side effects in case of Cotoneaster. Timepoint: Every 24 hours for 5 days. Method of measurement: Observation and complete check list.;The frequency of defecation. Timepoint: Daily. Method of measurement: Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Azadbakht
Fharmacy Department, Mazandaran University of Medical Sciences
Outcome results
None listed